|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn476059715 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr mn|---||||| |
008 |
091207s2002 vtu o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d NRU
|d OCLCQ
|d REDDC
|d OCLCF
|d OCLCO
|d OCLCL
|
020 |
|
|
|a 9780080491363
|q (electronic bk.)
|
020 |
|
|
|a 0080491367
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)476059715
|
050 |
|
4 |
|a RC271.G45G485 2002eb
|a RC271.G45 G485 2002
|a RC271.G45G485 2002
|
082 |
0 |
4 |
|a 616.994042
|a 616.99/4042 21
|a 616.9940426
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Lattime, Edmund C.
|
245 |
1 |
0 |
|a Gene Therapy of Cancer :
|b Translational Approaches from Preclinical Studies to Clinical Implementation.
|
260 |
|
|
|a Burlington :
|b Elsevier,
|c 2002.
|
300 |
|
|
|a 1 online resource (555 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a The Second Edition of Gene Therapy of Cancer provides crucial updates on the basic science and ongoing research in this field, examining the state of the art technology in gene therapy and its therapeutic applications to the treatment of cancer. The clinical chapters are improved to include new areas of research and more successful trials. Chapters emphasize the scientific basis of gene therapy using immune, oncogene, antisense, pro-drug activating, and drug resistance gene targets, while other chapters discuss therapeutic approaches and clinical applications. This book is a valuable reference.
|
505 |
0 |
|
|a Front Cover; Gene Therapy of Cancer; Copyright Page; Contents; Contributors; Preface; PART I: VECTORS FOR GENE THERAPY OF CANCER; PART II: IMMUNE TARGETED GENE THERAPY; PART IIa: VACCINE STRATEGIES; PART IIb: DENDRITIC CELL-BASED GENE THERAPY; PART IIc: CYTOKINES AND CO-FACTORS; PART IId: GENETICALLY MODIFIED EFFECTOR CELLS FOR IMMUNE-BASED IMMUNOTHERAPY; PART III: ONCOGENE-TARGETED GENE THERAPY; PART IV: MANIPULATION OF DRUG RESISTANCE MECHANISMS BY GENE THERAPY; PART V: ANTI-ANIOGENESIS AND PRO-APOPTOTIC GENE THERAPY; PART VI: PRODRUG ACTIVATION STRATEGIES FOR GENE THERAPY OF CANCER; Index.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Cancer
|x Gene therapy.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
4 |
|a Gene therapy.
|
650 |
|
4 |
|a Gene Transfer.
|
650 |
|
4 |
|a Immunotherapy, Adoptive.
|
650 |
|
4 |
|a Neoplasms.
|
650 |
|
4 |
|a Translation, Genetic.
|
650 |
|
4 |
|a Cancer.
|
650 |
|
6 |
|a Cancer
|x Thérapie génique.
|
650 |
|
6 |
|a Cancer
|x Immunothérapie.
|
650 |
|
7 |
|a Cancer
|x Gene therapy
|2 fast
|
650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|
700 |
1 |
|
|a Gerson, Stanton L.
|
758 |
|
|
|i has work:
|a Gene therapy of cancer (Work)
|1 https://id.oclc.org/worldcat/entity/E39PCGYRqghhHGhhf7RffqGDtq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
1 |
|
|z 9780124375512
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=294605
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL294605
|
994 |
|
|
|a 92
|b IZTAP
|